Antagonists of the brandykinin B1 receptor

Details Antagonists of the brandykinin B1 receptor Antagonists of the brandykinin B1 receptor

2004-10-21

2009-10-20

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S013800, C514S015800, C530S326000, C530S328000

Reexamination Certificate

active

07605120

ABSTRACT:
The present invention relates to certain biologically active peptides and conjugated peptides which can be used as therapeutics or prophylactics against diseases or conditions linked to B1 as the causative agent. In a preferred embodiment of the invention biologically active PEG-conjugated peptides are provided. In one aspect of the present invention, pharmacologically active PEG-conjugated peptides of the present invention are useful to treat inflammation or pain.

REFERENCES:
patent: 4693993 (1987-09-01), Stewart et al.
patent: 4801613 (1989-01-01), Stewart et al.
patent: 4923963 (1990-05-01), Stewart et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5385889 (1995-01-01), Kyle et al.
patent: 5416191 (1995-05-01), Cheronis et al.
patent: 5444048 (1995-08-01), Kyle
patent: 5541286 (1996-07-01), Kyle
patent: 5648333 (1997-07-01), Henke et al.
patent: 5648336 (1997-07-01), Stewart et al.
patent: 5700779 (1997-12-01), Goodfellow et al.
patent: 5834431 (1998-11-01), Stewart et al.
patent: 5849863 (1998-12-01), Stewart et al.
patent: 5863899 (1999-01-01), Cheronis et al.
patent: 5935932 (1999-08-01), Stewart et al.
patent: 6075120 (2000-06-01), Cheronis et al.
patent: 6388054 (2002-05-01), Stewart et al.
patent: 6407207 (2002-06-01), Borkowski et al.
patent: 2435642 (1976-02-01), None
patent: 0318162 (1989-05-01), None
patent: 0885899 (1998-12-01), None
patent: WO98/07746 (1998-02-01), None
patent: WO01/62827 (2001-08-01), None
Regoli Domenico, et al., Bradykinin receptors and their antagonists. European Journal of Pharmacology, 348:1-10 (1998).
Stewart, John M., et al., Bradykinin antagonists: present progress and future prospects. Immunopharmacology, 43:155-161 (1999).
Stewart, John M., et al., Metabolism-Resistant Bradykinin Antagonists: Development and Applications. Biol. Chem., 382:37-41 (2001).
Morpurgo, Margherita, et al., Selective Alkylation and Acylation of αand βAmino Groups with PEG in a Somatostatin Analogue: Tailored Chemistry for Optimized Bioconjugates. Bioconjugate Chem. 13:1238-1243 (2002).
Neugebauer, Witold, et al., Kinin B1receptor antagonists with multi-enzymatic resistance properties. Can. J. Physiol. Pharmacol., 80:287-292 (2002).
Raymond, Philippe, et al. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J. Immun. Methods, 180:247-157 (1995).
Anderson, K.P., et al., “Primary Structure of a Gene Encoding Rat T-Kininogen” Gene (Amsterdam), 81(1); 119-128 (1989).
Zalipsky, S. et al., “Use ethylene glycol chemistry of Funcationalized Poly-Ethylene Glycol)s for Modificatioin of Polypeptides” Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications 1992, 347-3703:155-161 (1999).

Affiliated with

Also associated with

Rating

Antagonists of the brandykinin B1 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antagonists of the brandykinin B1 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of the brandykinin B1 receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4052834